This study also showed that DHA supplementation restrained expression of FoxO1 and FoxO3 in pig adipocytes and human kidney HEK293T cells, suggesting that FoxO are potential therapeutic targets for DHA in ameliorating metabolic syndromes. The gene discussed is FOXO3; the disease is metabolic syndrome.